Crispr therapeutics insider trading
WebApr 12, 2024 · Kistler Tiffany Companies LLC grew its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP - Get Rating) by 439.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission.The firm owned 4,217 shares of the company's stock after acquiring an additional 3,435 shares … WebApr 1, 2024 · CRISPR Therapeutics AG (NASDAQ:CRSP - Get Rating) CEO Samarth Kulkarni sold 25,000 shares of the company's stock in a transaction dated Wednesday, March 29th. The stock was sold at an average price of $44.46, for a total value of $1,111,500.00. Following the transaction, the chief executive officer now directly owns …
Crispr therapeutics insider trading
Did you know?
Web4 rows · 12/20/2024. Option Execute. Direct. 17,750. $1.81. 279,085. Back to CRSP Overview. Insider ... WebInsider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crispr Therapeutics Ag (CRSP) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Crispr Therapeutics Ag. Table 2 shows the detailed insider transactions. This company's CIK number is 1674416.
Web10 rows · Apr 9, 2024 · How much insider selling is happening at CRISPR Therapeutics? Insiders have sold a total of ... WebApr 6, 2024 · The main competitors of CRISPR Therapeutics include Denali Therapeutics (DNLI), Vir Biotechnology (VIR), Vaxcyte (PCVX), Abcam (ABCM), Ginkgo Bioworks (DNA), Immunocore (IMCR), Beam Therapeutics (BEAM), Relay Therapeutics (RLAY), Krystal Biotech (KRYS), and Halozyme Therapeutics (HALO). These companies are all part of …
Web2 days ago · Complete CRISPR Therapeutics AG stock information by Barron's. View real-time CRSP stock price and news, along with industry-best analysis. Web18 hours ago · InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Against the backdrop of a solid day on Wall Street, CRISPR Therapeutics (NASDAQ:CRSP) …
WebFind the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.
WebGet the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … promo threeWebMar 14, 2024 · In the last 7 years, insiders at Crispr Therapeutics Ag have sold an estimated value of $398.31M and bought an estimated value of $59M worth of shares. Insider trading is most common in June ... laboratory\\u0027s 2qWebApr 13, 2024 · Shares of CRISPR Therapeutics stock opened at $43.47 on Thursday. CRISPR Therapeutics has a 52 week low of $38.94 and a 52 week high of $86.95. The stock has a 50 day moving average price of $47.74 and a two-hundred day moving average price of $50.87. The stock has a market capitalization of $3.42 billion, a PE ratio of -5.19 … promo thrifty car rental codesWebApr 11, 2024 · 18 Wall Street research analysts have issued 1 year price objectives for CRISPR Therapeutics' stock. Their CRSP share price forecasts range from $39.00 to … laboratory\\u0027s 2vWebApr 13, 2024 · CRSP has an average price target of $84.19 among all 26 analysts with coverage of the stock. That implies an upside of about 68%. However, insider activity over the past three years paints a ... laboratory\\u0027s 2sWebApr 14, 2024 · CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by solid volume with far more shares changing hands than in a normal session ... promo ticket airlinesWebCRSP Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is … laboratory\\u0027s 2u